abstract |
To inhibit at least one of C3b binding to factor B and properdin, to inhibit C3 cleavage, to inhibit activation of neutrophils, monocytes, platelets and endothelium, or to form C3a, C5a and MAC A method of inhibiting complement activation mediated by a C3b inhibitor in a subject comprising administering to the subject a C3b inhibitor to inhibit. [Selection] Figure 1 |